Methods: Diabetes was induced in four male Yorkshire pigs via intravenous injection of 150 mg/kg streptozotocin. Pig ASCs were harvested and cultured in M199 or EGM-2 medium with 30 mm glucose. Fourteen circular dorsal wounds (5 cm diameter; 5 mm depth) were created. Duplicate wounds were treated with one of four cell-based therapies by injection of 5 million (M) ASCs, 10 M ASCs, 5 M ED ASCs, or 10 M ED ASCs on day 0 and half the initial dose on day 15. Wounds assigned to the topical CM therapy were covered with 2 cc of either serum free M199 primed by ASCs or human umbilical vein endothelial cells every 3 days. One set of wounds was designated as the control. Wounds were assessed at days 0, 10, 15, 20, and 28. Animals were sacrificed on day 28. ImageJ software was used to evaluate the percentage of wound healing.
Objectives: The traditional approach to stable blunt thoracic aortic injury (BTAI) endorsed by the Society for Vascular Surgery is urgent thoracic endovascular aortic repair (TEVAR). Recently, some studies have suggested a potential mortality benefit in stable BTAI patients repaired in a delayed manner (>24 hours). However, the indications for use of delayed TEVAR for BTAI are not well characterized, and its overall impact on patient survival remains poorly understood. We sought to determine whether delayed TEVAR would be associated with a decrease in mortality compared to early TEVAR in this population.
Methods: We conducted a retrospective cohort study of adult patients with BTAI (International Classification of Diseases-9 diagnosis code 901.0) who underwent TEVAR (International Classification of Diseases-9 procedure code 39.73) from 2009 to 2013 using the National Sample Program data set. Missing physiologic data was imputed using chained multiple imputation. Patients were parsed into groups based on the timing of TEVAR (early <24 hours vs delayed $24 hours). Mann-Whitney and c 2 and tests were used to compare baseline characteristics between groups. Multivariable logistic regression for mortality was performed that included all variables significant at P # .2 in univariate analyses.
Results: We identified 2045 adult patients with BTAI, of whom 534 (26%) underwent TEVAR (74% male, 70% Caucasian). Median age was 41 years (interquartile range [IQR] , 27-56 years), median Injury Severity Score was 34 (IQR, (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) , and median Glasgow Coma Scale motor score was 6 (IQR, 4-6). Of TEVAR patients, 378 underwent early repair and 129 underwent delayed repair. Patients with missing data on TEVAR timing were excluded (n ¼ 27). Baseline characteristics of the two groups are reported in the Table. Mortality was 11.9% in the early TEVAR group vs 5.7% in the delayed group, with the early group displaying a higher odds ratio of 2.33 (95% confidence interval, 1.03-5.36). After adjusting for age and admission motor Glasgow Coma Scale, the association between early TEVAR and mortality was strengthened (odds ratio, 2.44; 95% confidence interval, 1.05-5.72).
Conclusions: Consistent with current Society for Vascular Surgery recommendations, more BTAI patients underwent early TEVAR than delayed TEVAR during the study period. However, delayed TEVAR was associated with significant survival benefit in this population. Together, these findings support a need for critical appraisal and clarification of existing practice guidelines in management of BTAI. Future studies should seek to understand this Objectives: Endovascular repair of the thoracic aorta (TEVAR) is the preferred treatment for blunt thoracic aortic injury (BTAI). Current stent grafts recommend a >20 mm proximal landing zone of healthy aorta, but these guidelines were based on treatment of aneurysms. Given the location of BTAI, this would often necessitate coverage of the left subclavian artery (LSA). In these often-healthier aortas, a shorter proximal landing zone may be acceptable. Current practice patterns still vary greatly regarding LSA coverage, and long-term effects of LSA coverage remain unknown.
Methods: A total of 28 TEVARs, with 20 preserving the LSA and eight covering, were performed for BTAI over the past 10 years. The primary outcome was failure of sealing, endoleak, or lack of aortic healing on follow-up scans. TeraRecon medical imaging software (Foster City, CA) was used to examine the centerline length of healthy aorta from the LSA to the injury. Initial post-TEVAR computed tomography (CT) scans were examined for evidence of persistent dissection, pseudoaneurysm, or hematomas.
Results: Mean age of the patients was 38.9 (standard deviation [SD], 20.2) years, with 71.4% male. The average Injury Severity Score was 36.75 (SD, 13.1). Treated patients had BTAI consisting of grade II (39%) or III (61%) injuries. In the uncovered cases, mean length of LSA to injury was 15.2 (SD, 8.4) mm of which 13 (65%) cases were <20 mm and seven (35%) were between 5 and 10 mm. In the eight covered cases, the mean length from the LSA was 2.9 (SD, 3.8) mm, of which 6 (75%) were <5 mm. Overall there was a 100% technical success rate with no evidence of endoleak or failure to seal. On follow-up imaging within 60 days there was no evidence of persistent aortic injury or endoleak in all surviving patients (n ¼ 25). Two patients (7%) died of massive intracranial injury, and one patient was lost to follow-up. Longterm follow-up (>1 year) was only 46.4%, but of these there was no evidence of endoleak or graft migration.
Conclusions: TEVAR for BTAI in patients with short proximal landing zones of 5 to 10 mm appears to be safe and efficacious to achieve healing. The aorta appears to heal quickly after TEVAR, with the graft acting more as a bridge to allow healing. Long-term issues regarding LSA coverage are unknown, and preservation should be attempted even in patients with short proximal landing zones.
Author Disclosures: S. A. Loh: Nothing to disclose; D. Novikov: Nothing to disclose; E. Skripochnik: Nothing to disclose.
PC174.

Outcomes in Endovascular Therapy for Popliteal Artery Injuries After Total Knee Replacement
Henry Hirsch, Robert J. Meisner, Vincent M. DiGiovanni, Alexander Uribe. Lankenau Medical Center, Wynnewood, Pa
Objectives: Popliteal artery injury is a rare but serious complication of total knee arthroplasty (TKA). Incidence of these injuries ranges from 0.03% to 0.51%. Endovascular techniques are emerging as safe and effective approaches to popliteal injury. Cases of popliteal artery injury treated with endovascular therapies have been published, although there have been no large series or prospective analysis. In this study, we reviewed the experience and reported the safety and efficacy of popliteal stenting for management of the orthopedic vascular complication.
Methods: Patients undergoing TKA complicated by popliteal artery injury between December 2011 and June 2016 were identified in the medical record at a single high-volume center. All patients who underwent endovascular therapy for popliteal artery injury were included in the analysis. Data were extracted by a single reviewer.
Results: Ten patients undergoing endovascular therapy for popliteal artery injury during TKA were identified. Eight were primary procedures, and two were redo TKA procedures. Mean age was 65 years, with eight female patients and two male patients. No patient had previously documented peripheral vascular disease. In 90% of cases, the popliteal injury was a focal dissection and was recognized as acute ischemia in the postanesthesia unit. In these cases, intervention was conducted the same day. In one patient, popliteal laceration was identified 24 hours after TKA, and popliteal angiography was performed emergently. Endovascular therapy was successful in all cases, and there were no conversions to open surgery. All patients were treated with a Viabahn stent graft (W. L. Gore and Associates, Newark, Del). Intravascular ultrasound imaging was used in 70% cases to assess vessel diameter and a minimal 5% stent graft oversizing was used. Follow-up with duplex examination results were available in all patients, with a mean follow-up of 13 months (range, 1-45 months). Primary patency at follow-up was 100% in this sample. Procedural complications included retroperitoneal hematoma in one patient, who did not require intervention, one patient experienced pulmonary embolus, and chronic numbness of the lower leg occurred in one patient. No patients required secondary intervention for limb salvage.
Conclusions: Endovascular therapy for popliteal artery injury during TKA is safe and effective, with excellent midterm patency in this sample. Procedural complications were related to the magnitude of the original orthopedic surgery in most cases. Long-term data in a large sample are needed to draw conclusions about the ultimate durability to this approach. Objectives: To study describes an alternative revascularization approach to the gold standard reverse saphenous vein graft bypass for blunt traumatic popliteal artery injuries and demonstrates the feasibility and effectiveness of endovascular revascularization following posterior knee dislocation and subsequent arterial flowlimiting injury.
Methods: This was a retrospective descriptive review of three posterior knee dislocations resulting in arterial injury repaired through endovascular technique. These three cases were performed by one of two experienced vascular surgeons from March 2015 to August 2015.
Results: All patients presented to a tertiary care center within 6 hours of the initial injury with hard signs of arterial insufficiency (Fig  1) . Arterial access was obtained in a hybrid operating suite, and the popliteal artery injuries were traversed. This was accomplished antegrade in one patient and retrograde from distal arterial access in
